- Home
- BABA vs AZN Comparison
BABA vs AZN Comparison
Compare BABA & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BABA
- AZN
- Stock Information
- Founded
- BABA 1999
- AZN 1992
- Country
- BABA China
- AZN United Kingdom
- Employees
- BABA N/A
- AZN N/A
- Industry
- BABA Business Services
- AZN Biotechnology: Pharmaceutical Preparations
- Sector
- BABA Consumer Discretionary
- AZN Health Care
- Exchange
- BABA Nasdaq
- AZN Nasdaq
- Market Cap
- BABA 253.6B
- AZN 205.5B
- IPO Year
- BABA 2014
- AZN 1993
- Fundamental
- Price
- BABA $108.87
- AZN $67.59
- Analyst Decision
- BABA Strong Buy
- AZN Strong Buy
- Analyst Count
- BABA 14
- AZN 7
- Target Price
- BABA $154.15
- AZN $89.75
- AVG Volume (30 Days)
- BABA 29.6M
- AZN 6.8M
- Earning Date
- BABA 05-13-2025
- AZN 04-29-2025
- Dividend Yield
- BABA 0.90%
- AZN 2.28%
- EPS Growth
- BABA 27.15
- AZN 18.11
- EPS
- BABA 6.75
- AZN 4.50
- Revenue
- BABA $134,505,212,800.00
- AZN $54,073,000,000.00
- Revenue This Year
- BABA $8.34
- AZN $8.64
- Revenue Next Year
- BABA $7.12
- AZN $6.11
- P/E Ratio
- BABA $16.12
- AZN $29.58
- Revenue Growth
- BABA 5.85
- AZN 18.04
- 52 Week Low
- BABA $68.36
- AZN $61.24
- 52 Week High
- BABA $148.43
- AZN $87.68
- Technical
- Relative Strength Index (RSI)
- BABA 39.53
- AZN 40.79
- Support Level
- BABA $105.95
- AZN $66.81
- Resistance Level
- BABA $116.00
- AZN $68.40
- Average True Range (ATR)
- BABA 5.98
- AZN 2.22
- MACD
- BABA -1.39
- AZN -0.19
- Stochastic Oscillator
- BABA 34.25
- AZN 43.91
About BABA Alibaba Group Holding Limited
Alibaba is the world's largest online and mobile commerce company as measured by gross merchandise volume. It operates China's online marketplaces, including Taobao (consumer-to-consumer) and Tmall (business-to-consumer). The China commerce retail division is the most valuable cash flow-generating business at Alibaba. Additional revenue sources include China commerce wholesale, international commerce retail/wholesale, local consumer services, cloud computing, digital media and entertainment platforms, Cainiao logistics services, and innovation initiatives/other.
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.